•  
  •  
  •  
  •  

2026-02-19 18:52:09

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Steelco Gujarat Launches ₹14.9 Cr Rights Issue
  • INOXGFL Group Companies Emerge as Successful Bidders For Wind World India's IPP and O&M Arms
  • Embraer and Mahindra Group Advance Localization Strategy in India with Planned C-390 Millennium MRO Capability
  • Hemant Surgical Bags ₹264 Cr Medical Equipment Order from Govt
  • LTM Partners with Indian Institute of Creative Technologies to build India's NextGeneration Creative Technology Talent Pipeline

Keywords Selected:  ExtendedReleaseCapsules

Stock Report

  • Zydus receives approval from China's NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg
  • Alembic Pharmaceuticals announces USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg
  • Zydus receives final approval from USFDA for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg
  • Ajanta Pharma Ltd receives final approval from US FDA for Topiramate Extended Release Capsules
  • Granules India Limited Received ANDA Approval for Venlafaxine ER Capsules
  • Zydus receives final approval from the USFDA for Topiramate Extended-Release Capsules
  • Alembic Pharmaceuticals receives USFDA Final Approval for Mesalamine Extended-Release Capsules USP, 0.375 g
  • Zydus receives tentative approval from the USFDA for Amantadine Extended-Release Capsules
  • Sun Pharma announces US FDA Approval for Generic Mesalamine Extended Release Capsules

Latest Post

  • Steelco Gujarat Launches ₹14.9 Cr Rights Issue
  • INOXGFL Group Companies Emerge as Successful Bidders For Wind World India's IPP and O&M Arms
  • Embraer and Mahindra Group Advance Localization Strategy in India with Planned C-390 Millennium MRO Capability
  • Hemant Surgical Bags ₹264 Cr Medical Equipment Order from Govt
  • LTM Partners with Indian Institute of Creative Technologies to build India's NextGeneration Creative Technology Talent Pipeline


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025